Us-china Biomedical Technology, Inc. Net Income per Employee (CLDS), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Us-china Biomedical Technology, Inc.  (CLDS)
    Sector • Services    Industry • Advertising
   Industry • Advertising
   Sector • Services
 

Us-china Biomedical Technology Net Income per Employee

CLDS's Quarterly Results, Trends, Rankings, Statistics
Us-china Biomedical Technology, Inc. recorded a cumulative net loss of $-1 million during 12 month ending in the first quarter 2020.
The Services sector has seen employees of 14 other companies achieving higher income per employee. While Us-china Biomedical Technology's total ranking has deteriorated compared to the previous quarter from 1948 to 3211.


What is Income per Employee Ratio?






CLDS Net Income per Employee (May 31 2019)
I. Quarter
(Feb 28 2019)
IV. Quarter
(Nov 30 2018)
III. Quarter
(Aug 31 2018)
II. Quarter
(May 31 2018)
I. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -279,499 -355,470 -306,329 -312,432 -358,389
CLDS's Total Ranking # 3211 # 1948 # 2155 # 1956 # 1949
Seq. Net Income Change - - - - -


CLDS Net Income per Employee Company Ranking
Within: No.
Advertising Industry # 15
Services Sector # 413
Overall Market # 3211

Net Income per Employee Statistics
High Average Low
$ 575,393 $ 2,231 $ -358,389
(Aug 31 2016)   (May 31 2018)







Companies with similar Income per Employee for 12 month ending May 31 2019, within Services Sector Income per Employee Income 12 month ending May 31 2019Number of Employees May 31 2019


Date modified: 2026-09-08T15:09:36+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.